Such treatment led to a decrease in binding of Clock to Bmal1 and a downregulation of Bhlhe41 and Dnajb4 expression, resulting in NCLX upregulation and an improvement in mitochondrial calcium overload, hippocampal neuron dysfunction, and cognitive impairment in diabetes. Here, BMAL1 is linked to diabetes mellitus.